Table 6 Clinical characteristics of 625 patients based on HB classification.

From: A new glioma grading model based on histopathology and Bone Morphogenetic Protein 2 mRNA expression

HB

n

Age (year)

IDH1 mutation (yes/no/NA)

1p19q LOH (yes/no/NA)

Mean BMP2

HBs

0

0

0

0

0

HBh

301

43.64 ± 0.78

NA

NA

10.18 ± 0.08

HBm

180

42.02 ± 0.94

NA

NA

9.24 ± 0.12

HBl

144

59.97 ± 1.10

NA

NA

7.79 ± 0.09

Total

625

46.94 ± 0.60

NA

NA

9.36 ± 0.07